EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice

Tatsuya Nakatani iD, Shinya Sato iD, Kosuke Kaji, Hiroki Kachi, Naoki Nishimura, Masafumi Oyama, Jun-Ichi Hanatani iD, Satoshi Iwai iD, Soichi Takeda, Norihisa Nishimura iD, Koh Kitagawa iD, Tadashi Namisaki iD und 1 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27146485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Tatsuya Nakatani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan. Hauptthemen laut MEDLINE: Diet, High-Fat, Milk, Extracellular Vesicles, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut barrier dysfunction and portal endotoxemia contribute to metabolic dysfunction-associated steatohepatitis (MASH) progression through activation of hepatic inflammatory signaling. Milk-derived extracellular vesicles (EVs) contain bioactive microRNAs and have recently attracted attention as modulators of intestinal homeostasis. This study investigated the effect of bovine milk-derived extracellular vesicles (B-mEVs) in ameliorating MASH by improving intestinal barrier function. C57BL/6J mice fed a choline-deficient amino acid-defined high-fat diet (CDA-HFD) were orally treated with B-mEVs, and therapeutic effects were evaluated. Liver histology, fibrosis, portal lipopolysaccharide (LPS) levels, intestinal permeability, and gut microbiota composition were evaluated. The direct effects of B-mEVs on intestinal barrier function were assessed using palmitic acid-stimulated Caco-2 cells. Small RNA sequencing and microRNA enrichment analyses were performed to characterize B-mEV cargo. B-mEV treatment attenuated hepatic steatosis, inflammation, and fibrosis in CDA-HFD-fed mice and reduced serum aminotransferase levels, portal LPS concentrations, hepatic macrophage accumulation, and hepatic TLR4/NF-κB signaling activation. Meanwhile, B-mEVs restored intestinal tight junction proteins, including ZO-1, occludin, and claudin-1, and improved intestinal permeability in vivo. In Caco-2 cells, B-mEVs attenuated palmitic acid-induced barrier dysfunction and suppressed myosin light chain kinase expression. Gut microbiota analysis revealed partial restoration of Akkermansia abundance after B-mEV administration. Furthermore, to explore the molecular basis of these protective effects, small RNA sequencing demonstrated enrichment of regulatory microRNAs, including let-7a-5p, and pathway analyses identified associations with intestinal barrier and inflammatory signaling pathways. B-mEVs ameliorated CDA-HFD-induced steatohepatitis by restoring intestinal barrier integrity and suppressing gut-derived LPS/TLR4 inflammatory signaling. These findings suggested that milk EVs may represent a novel gut–liver axis-targeted therapeutic strategy for MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatMilkExtracellular VesiclesFatty LiverAnimalsMiceHumansIntestinal Barrier FunctionCattleMice, Inbred C57BLCaco-2 CellsMaleMicroRNAsLiverSignal TransductionGastrointestinal MicrobiomeToll-Like Receptor 4Intestinal Mucosa

Stichwörter der Autor:innen

extracellular vesiclesgut–liver axisintestinal barriermetabolic dysfunction-associated steatohepatitismicrobiota

Substanzen

MicroRNAsToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.

ORCID-Profile: Tatsuya Nakatani, Shinya Sato, Jun-Ichi Hanatani, Satoshi Iwai, Norihisa Nishimura, Koh Kitagawa, Tadashi Namisaki

Zitieren

APA

Nakatani, T., Sato, S., Kaji, K., Kachi, H., Nishimura, N., Oyama, M., Hanatani, J. I., Iwai, S., Takeda, S., Nishimura, N., Kitagawa, K., Namisaki, T., & Yoshiji, H. (2026). Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146485

Vancouver

Nakatani T, Sato S, Kaji K, Kachi H, Nishimura N, Oyama M, et al. Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146485

BibTeX
@article{Nakatani2026,
  author = {Nakatani, Tatsuya and Sato, Shinya and Kaji, Kosuke and Kachi, Hiroki and Nishimura, Naoki and Oyama, Masafumi and Hanatani, Jun-Ichi and Iwai, Satoshi and Takeda, Soichi and Nishimura, Norihisa and Kitagawa, Koh and Namisaki, Tadashi and Yoshiji, Hitoshi},
  title = {Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27146485}
}
Kostenlos starten →